Following a massive 162 percent surge in prescriptions and a major FDA label reversal, a critical shortage of estradiol ...
Topical estrogen and systemic menopausal hormone therapy did not improve hair growth for women going through menopause, ...
Estrogen patches are in short supply as demand for menopause treatments skyrockets, and it could take at least a year for ...
The Food and Drug Administration removed the black box warning from hormone replacement therapies late last year, and recently, the most insured type, the estrogen patch, has been in short supply amid ...
Physicians have spent years working to improve the care for women in menopause and perimenopause − from training providers to setting standards for hormone replacement therapy. Now they fear a lack of ...
PITTSBURGH, May 1, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined hormonal ...
If you want to talk about estrogen, it’s impossible to avoid the topic of reproduction. The sex hormone makes puberty, periods, and pregnancy possible. But new research is redefining this hormone, ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Since the beginning of the year, there have been multiple reports of ...
Alexis Dunne always plans how to best treat her patients’ perimenopause and menopause symptoms. The Chicago-area physician wants to ensure that the hormone replacement therapy she prescribes helps ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Shutterstock Demand for estrogen patches surged 26% after the FDA removed a black box ...
Easing safety warnings, shift in sentiment toward HRT trigger sharp increases in use Patients report pharmacy-hopping and dose changes Manufacturers say complex production limit rapid scale-up April 9 ...